Trial Profile
Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. A Phase I, Double Blind, Placebo Controlled, Safety Study. Stage 1
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sodium pyruvate (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Emphycorp
- 05 Jan 2016 New trial record